EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

A nationwide study: prevalence of rheumatoid factor and anti- citrullinated peptide positivity and their contribution to rheumatoid arthritis diagnosis

Hasan Satiş iD, Abdulsamet Erden iD, Emre Bilgin iD, Gizem Ayan iD, Berkan Armağan, Duygu Tecer iD, Alper Sari iD, Umut Kalyoncu iD, Murat Çağlayan iD, Mustafa Mahir Ülgü iD, Mustafa Okan Ayvali iD, Naim Ata iD und 1 weitere

Turkish Journal of Medical Sciences · 18.10.2024 · 54 (5) · 949-955

DOI: 10.55730/1300-0144.5872 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 18.10.2024. Verfasst von Hasan Satiş und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Abdurrahman Yurtaslan Oncology Research and Training Hospital, University of Health Scienc…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Rheumatoid Factor, Anti-Citrullinated Protein Antibodies. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AbstractAim: Rheumatoid factor (RF) and Anti Citrullinated Peptide (anti-CCP) is specific for rheumatoid arthritis (RA) diagnosis. However they could be positive in other disease and even healthy populations. It was aimed to investigate the prevalence of positive RF and anti-CCP antibodies in persons admitted to hospital for any reason and on a national scale.Material and Method: The National Electronic Health Database, which contains the clinical records of over eighty million people, is used to design this multi-center, retrospective cohort study. The subjects included in the study were divided into age groups in 10-year periods. RA cases were identified by using ICD-10 codes that included M05,M06, M08,and their subgroups. RF and anti-CCP positivity were evaluated in terms of their contribution to the risk of being diagnosed with RA, with the change according to age and genderResults: During the 1.1.2018-31.12.2021 period, 13.918.072 RF tests were performed in 11.849.440 people, whereas 1.183.607 anti-CCP test were performed in 1.020.967 people. 797.089 people had at least once both tests performed. RF positivity rate in patients who only requested RF test was 14.72% and it was 35.04% for anti-CCP positivity in only requested anti-CCP tests. The rate of concomitant RF and anti-CCP positivity was 22.56%.RA diagnosis is made in in 27.8% of RF-positive people, in 39.73% of anti-CCP-positive people and in %56.6 of co RF and anti CCP positive people. RF positivity and concomitant RF and anti-CCP positivity increased with the age and more common in females.Conclusion: RF and anti-CCP positivity could be seen in a healthy population with female predominance. As the age increases, the risk of RF positivity is increased, however anti –CCP positivity does not change. Concomitant RF and anti-CCP positivity has the highest risk of RA development with respect to either antibody positivity alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidRheumatoid FactorAnti-Citrullinated Protein AntibodiesHumansFemaleMaleMiddle AgedRetrospective StudiesAdultPrevalenceAgedYoung AdultTurkeyAdolescentAged, 80 and over

Stichwörter der Autor:innen

Autoantibodyanticitrullinated peptidenationwiderheumatoid arthritisrheumatoid factor

Substanzen

Rheumatoid FactorAnti-Citrullinated Protein Antibodies

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Internal Medicine, Abdurrahman Yurtaslan Oncology Research and Training Hospital, University of Health Sciences, Ankara, Turkiye.
  • Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Gazi University, Ankara, Turkiye.
  • Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkiye.
  • Division of Rheumatology, Department of Internal Medicine, Ankara Bilkent State Research and Training Hospital, University of Health Sciences, Ankara, Turkiye.
  • Division of Rheumatology, Department of Internal Medicine, Gülhane Research and Training Hospital, University of Health Sciences, Ankara, Turkiye.
  • Division of Rheumatology, Department of Internal Medicine, Ankara Etlik State Research and Training Hospital, University of Health Sciences, Ankara, Turkiye.

ORCID-Profile: Hasan Satiş, Abdulsamet Erden, Emre Bilgin, Gizem Ayan, Duygu Tecer, Alper Sari, Umut Kalyoncu, Murat Çağlayan, Mustafa Mahir Ülgü, Mustafa Okan Ayvali, Naim Ata, Şuayip Birinci

Zitieren

APA

Satiş, H., Erden, A., Bilgin, E., Ayan, G., Armağan, B., Tecer, D., Sari, A., Kalyoncu, U., Çağlayan, M., Ülgü, M. M., Ayvali, M. O., Ata, N., & Birinci, Ş. (2024). A nationwide study: prevalence of rheumatoid factor and anti- citrullinated peptide positivity and their contribution to rheumatoid arthritis diagnosis. Turkish Journal of Medical Sciences, 54(5), 949-955. https://doi.org/10.55730/1300-0144.5872

Vancouver

Satiş H, Erden A, Bilgin E, Ayan G, Armağan B, Tecer D, et al. A nationwide study: prevalence of rheumatoid factor and anti- citrullinated peptide positivity and their contribution to rheumatoid arthritis diagnosis. Turkish Journal of Medical Sciences. 2024;54(5):949-955. doi:10.55730/1300-0144.5872

BibTeX
@article{Sati2024,
  author = {Satiş, Hasan and Erden, Abdulsamet and Bilgin, Emre and Ayan, Gizem and Armağan, Berkan and Tecer, Duygu and Sari, Alper and Kalyoncu, Umut and Çağlayan, Murat and Ülgü, Mustafa Mahir and Ayvali, Mustafa Okan and Ata, Naim and Birinci, Şuayip},
  title = {A nationwide study: prevalence of rheumatoid factor and anti- citrullinated peptide positivity and their contribution to rheumatoid arthritis diagnosis},
  journal = {Turkish Journal of Medical Sciences},
  year = {2024},
  volume = {54},
  number = {5},
  pages = {949--955},
  doi = {10.55730/1300-0144.5872}
}
Kostenlos starten →